STOK
NASDAQ · Biotechnology
Stoke Therapeutics Inc
$26.60
+0.53 (+2.03%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+88.6% upside
Low Target
$29.72
Average Target
$50.17
High Target
$68.67
Current Price
$26.60
Current
$26.60
$26.60
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Scenario Analysis
Bear Case
$29.72
11.7%
Low target
Base Case
$50.17
+88.6%
Avg target
Bull Case
$68.67
+158.2%
High target
Risk/Reward
13.5x
Highly favorable
Price in Context
52-Week High
$40.22
-33.9% from high
52-Week Low
$20.32
+30.9% from low
Target vs 52W High
$50.17
+24.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |